Evidence map›Paper›PMID 24258832›Full record

ArticleThorax2014

Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation.

Stephen J Till, Eleanor J Raynsford, Catherine J Reynolds, Kathryn J Quigley, Agnieszka Grzybowska-Kowalczyk, Lavina R Saggar, Andrea Goldstone, Bernard Maillere, William W Kwok, Daniel M Altmann and 2 more

Abstract read
In one paragraph

Article in Thorax, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2015
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Stephen J TillDepartment of Asthma, Allergy and Respiratory Science, Division of Asthma, Allergy & Lung Biology, MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, , London, UK.
Eleanor J Raynsford
Catherine J Reynolds
Kathryn J Quigley
Agnieszka Grzybowska-Kowalczyk
Lavina R Saggar
Andrea Goldstone
Bernard Maillere
William W Kwok
Daniel M Altmann
Stephen R Durham
Rosemary J Boyton

Funding

Medical Research Council G1000758Medical Research Council G108/495NIAID NIH HHS HHSN272200700046CNIAID NIH HHS HHSN272200900046C
6 · The paper itself

Abstract

backgroundT-cell targeted peptide epitope tolerogens from grass pollen allergens may be useful in treating seasonal allergic rhinitis, but there is urgent need for optimisation of approaches from improved understanding of mechanism.

objectiveWe sought to identify human leukocyte antigen (HLA)-DR1-restricted epitopes from the Timothy grass pollen allergen, Phleum pratense, and characterise T-cell immune regulation following intranasal administration of a single, immunodominant epitope.

methodsT-cell epitopes within P pratense were identified using HLA-DR1 transgenic mice and tetramer-guided epitope mapping (TGEM) in HLA-DR1-positive individuals with grass allergy. An immunodominant epitope was tested in HLA-DR1 transgenics for impact on responses to whole Phl p5 b or peptide. Microarrays and quantitative PCR were used to characterise T-cell immunity.

resultsPeptide 26 (p26) was identified in HLA-DR1 transgenic mice and by TGEM analysis of HLA-DR1-positive individuals with grass allergy. p26 shows promiscuous binding to a wide range of HLA class II alleles, making it of relevance across immunogenetically diverse patients. The epitope is conserved in rye and velvet grass, making it applicable across a spectrum of grass pollen allergy. Intranasal pretreatment of mice with p26 results in significantly reduced T-cell responses. Transcriptomic array analysis in mice showed T-cell regulation in the intranasal treatment group associated with increased expression of members of the Cbl-b and Itch E3 ubiquitin ligase pathway.

conclusionsWe defined an immunodominant P pratense epitope, p26, with broad binding across multiple HLA class II alleles. Intranasal treatment of mice with p26 results in T-cell regulation to whole allergen, involving the Cbl-b and Itch regulatory pathway.

Indexed as

Adaptor Proteins, Signal TransducingAdultAllergensAnimalsCD4-Positive T-LymphocytesFemaleHLA-DR1 AntigenHumansImmunity, CellularImmunodominant EpitopesMaleMiceMice, TransgenicMicroarray AnalysisMiddle AgedPhleumAdaptor Proteins, Signal TransducingAllergensCblb protein, mouseHLA-DR1 AntigenImmunodominant EpitopesItch protein, mousePHLPVI protein, Phleum pratensePlant ProteinsProto-Oncogene Proteins c-cblUbiquitin-Protein LigasesAllergic lung diseaseLymphocyte Biology

Identifiers

PMID24258832
PMCPMC4368902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.